Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Aromatic Amino Acid [EPC]
Indian Frankincense (Boswellia serrata) is an aromatic resin extract classified as an Aromatic Amino Acid [EPC] and plant allergenic extract, primarily used for its potent anti-inflammatory properties in managing joint and digestive health.
Name
Indian Frankincense
Raw Name
INDIAN FRANKINCENSE
Category
Aromatic Amino Acid [EPC]
Drug Count
6
Variant Count
6
Last Verified
February 17, 2026
About Indian Frankincense
Indian Frankincense (Boswellia serrata) is an aromatic resin extract classified as an Aromatic Amino Acid [EPC] and plant allergenic extract, primarily used for its potent anti-inflammatory properties in managing joint and digestive health.
Detailed information about Indian Frankincense
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Indian Frankincense.
Indian Frankincense, scientifically known as Boswellia serrata, is a resinous extract derived from the sap of the Boswellia tree, native to India, Northern Africa, and the Middle East. In the context of modern clinical pharmacology, it is categorized under several Established Pharmacologic Classes (EPC), including Aromatic Amino Acid [EPC], Non-Standardized Plant Allergenic Extract [EPC], and Non-Standardized Food Allergenic Extract [EPC]. While traditionally used for centuries in Ayurvedic medicine, contemporary medicine recognizes it for its specific bioactive compounds, primarily boswellic acids, which exert significant physiological effects on the human inflammatory response.
Indian Frankincense belongs to a class of therapeutic agents often characterized as natural anti-inflammatories or phytopharmaceuticals. Unlike synthetic non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen, Indian Frankincense targets specific enzymatic pathways without the same level of gastrointestinal or cardiovascular risk typically associated with long-term NSAID use. It is important to note that while various extracts of Boswellia serrata have been studied in clinical trials, the FDA has not approved Indian Frankincense as a prescription drug for the treatment of specific medical conditions; rather, it is frequently available as a high-grade dietary supplement or used in standardized forms in clinical research settings.
The therapeutic efficacy of Indian Frankincense is primarily attributed to its pentacyclic triterpene phytonutrients, specifically 3-O-acetyl-11-keto-beta-boswellic acid (AKBA). At the molecular level, Indian Frankincense acts as a selective inhibitor of the enzyme 5-lipoxygenase (5-LOX). This enzyme is responsible for the biosynthesis of leukotrienes, which are powerful pro-inflammatory mediators involved in several chronic inflammatory diseases, including asthma, rheumatoid arthritis, and inflammatory bowel disease (IBD).
By inhibiting 5-LOX, Indian Frankincense reduces the production of leukotrienes (specifically LTB4), thereby decreasing the recruitment of white blood cells to the site of inflammation. Furthermore, research suggests that AKBA may also inhibit nuclear factor-kappa B (NF-κB), a protein complex that controls the transcription of DNA and is a master regulator of the inflammatory response. By modulating these pathways, Indian Frankincense helps to stabilize the cellular environment and reduce the degradation of connective tissues, such as cartilage in the joints.
Understanding how the body processes Indian Frankincense is crucial for optimizing its therapeutic benefits and minimizing potential risks.
While not currently an FDA-approved prescription medication, Indian Frankincense is widely utilized and studied for several inflammatory conditions. Healthcare providers may suggest its use for:
Indian Frankincense is available in several formulations to accommodate different therapeutic needs:
> Important: Only your healthcare provider can determine if Indian Frankincense is right for your specific condition. Because it is often sold as a supplement, quality and concentration can vary significantly between brands.
Dosage for Indian Frankincense varies significantly based on the condition being treated and the concentration of active boswellic acids in the specific product used. Standard clinical research often utilizes the following ranges:
Always start with the lowest effective dose as recommended by a healthcare professional to assess tolerance.
Indian Frankincense is not generally recommended for use in children or adolescents under the age of 18. There is a lack of robust clinical data regarding the safety, long-term developmental effects, and appropriate dosing of boswellic acids in pediatric populations. If a healthcare provider determines that a child requires Indian Frankincense, they will calculate a weight-based dose, but this should never be attempted without direct medical supervision.
Because Indian Frankincense is primarily eliminated through the biliary system (feces) rather than the kidneys, dose adjustments for patients with mild to moderate renal impairment are typically not required. However, patients with severe chronic kidney disease (CKD) should be monitored closely for any changes in systemic tolerability.
Since Indian Frankincense is extensively metabolized by the liver (CYP450 system), patients with hepatic impairment (e.g., cirrhosis, hepatitis) may experience increased systemic exposure. Healthcare providers may recommend a 50% dose reduction or avoid use entirely in cases of severe liver dysfunction.
No specific age-related dose adjustments are required for elderly patients. However, because older adults are more likely to have decreased renal/hepatic function and take multiple medications (polypharmacy), a conservative starting dose is advised to minimize the risk of drug interactions.
To ensure maximum efficacy and safety, follow these administration guidelines:
If you miss a dose, take it as soon as you remember with food. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up, as this increases the risk of gastrointestinal side effects.
Signs of a potential overdose of Indian Frankincense include severe nausea, vomiting, epigastric pain (pain in the upper abdomen), and skin rashes. While Indian Frankincense has a high safety margin and is not typically associated with life-threatening toxicity, an acute overdose should be managed by contacting a Poison Control Center or seeking emergency medical care. Treatment is generally supportive, focusing on gastrointestinal decontamination and symptom management.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or stop taking Indian Frankincense without medical guidance, especially if you are using it for a chronic inflammatory condition.
Most individuals tolerate Indian Frankincense well, but some may experience mild gastrointestinal symptoms. These are usually dose-dependent and include:
These symptoms often resolve within a few days of consistent use or by ensuring the supplement is taken with a substantial meal.
> Warning: Stop taking Indian Frankincense and call your doctor immediately if you experience any of these serious symptoms:
Data on the continuous use of Indian Frankincense for more than 12 months is limited. Long-term use appears generally safe; however, there is a theoretical risk of:
No FDA black box warnings currently exist for Indian Frankincense. As a botanical extract, it does not carry the same regulatory mandates as synthetic prescription drugs. However, patients should treat it with the same caution as any bioactive pharmacological agent.
Report any unusual symptoms or persistent side effects to your healthcare provider immediately. Monitoring of liver function may be recommended for patients planning to use high doses of Indian Frankincense for extended periods.
Indian Frankincense is a potent bioactive substance that can influence multiple physiological systems. It is not "just a supplement"; it acts as a 5-LOX inhibitor and can interact with various biological pathways. Patients with pre-existing medical conditions must consult a healthcare provider before use.
There are currently no FDA black box warnings for Indian Frankincense. It is classified as "Generally Recognized as Safe" (GRAS) by the FDA when used as a food additive, though therapeutic doses are significantly higher than food-level exposure.
If you are taking Indian Frankincense for a chronic condition, your doctor may require the following monitoring:
Indian Frankincense generally does not cause sedation or cognitive impairment. However, if you experience dizziness or lightheadedness during the first few days of use, avoid driving or operating heavy machinery until you know how the supplement affects you.
There are no known direct chemical interactions between Indian Frankincense and alcohol. However, both substances are processed by the liver. Excessive alcohol consumption while taking Indian Frankincense may increase the risk of gastrointestinal irritation and liver strain. It is best to limit alcohol intake while using this supplement for therapeutic purposes.
Indian Frankincense does not typically cause a withdrawal syndrome. However, for patients using it to manage chronic inflammatory conditions like Ulcerative Colitis or Asthma, stopping the supplement suddenly may lead to a "rebound" flare-up of symptoms. It is often best to taper the dose over one to two weeks while monitoring for the return of inflammatory markers.
> Important: Discuss all your medical conditions, including any history of liver disease or allergies, with your healthcare provider before starting Indian Frankincense.
While few absolute contraindications exist, Indian Frankincense should never be used with:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A comprehensive review of your medication list is the only way to prevent dangerous interactions.
Indian Frankincense must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis by a physician include:
Individuals who are allergic to Myrrh, Palo Santo, or Common Frankincense (*Boswellia carterii*) are at a high risk of cross-sensitivity. If you have had a skin reaction or respiratory distress when exposed to these resins in incense or essential oils, you should not ingest Indian Frankincense.
> Important: Your healthcare provider will evaluate your complete medical history, including any rare allergies or chronic conditions, before recommending Indian Frankincense as part of your treatment plan.
Indian Frankincense is classified as possibly unsafe during pregnancy when used in therapeutic amounts.
It is unknown whether the active components of Indian Frankincense, such as AKBA, pass into human breast milk. Due to the lack of safety data regarding its effects on nursing infants—including potential impacts on the infant's developing immune system or liver—its use is not recommended while breastfeeding. Healthcare providers generally suggest safer, better-studied alternatives for inflammation during lactation.
Indian Frankincense is not approved for use in children. The Non-Standardized Food Allergenic Extract [EPC] classification implies a risk of developing new sensitivities in pediatric patients. Furthermore, the effects of 5-LOX inhibition on the developing immune system and growth plates are not well understood. Do not administer this supplement to children unless under the direct guidance of a pediatric specialist.
Elderly patients (65 and older) may benefit from the anti-inflammatory effects of Indian Frankincense for osteoarthritis. However, this population is at a higher risk for:
In patients with mild to moderate renal impairment, Indian Frankincense appears safe as it is not significantly cleared by the kidneys. In patients on hemodialysis, the protein-binding nature of boswellic acids means they are unlikely to be cleared by dialysis. Use in this population should be monitored by a nephrologist to prevent accumulation.
For patients with liver disease, Indian Frankincense should be used with extreme caution.
> Important: Special populations require individualized medical assessment to ensure that the benefits of Indian Frankincense outweigh the potential risks.
Indian Frankincense operates through a unique non-redox, non-competitive inhibition of the enzyme 5-lipoxygenase (5-LOX). Specifically, 3-O-acetyl-11-keto-beta-boswellic acid (AKBA) binds to a unique site on 5-LOX that is distinct from the substrate binding site. This binding prevents the conversion of arachidonic acid into 5-hydroperoxyeicosatetraenoic acid (5-HPETE), the precursor to pro-inflammatory leukotrienes.
In addition to 5-LOX inhibition, Indian Frankincense has been shown to:
| Parameter | Value |
|---|---|
| Bioavailability | Low (Significantly increased with fats) |
| Protein Binding | >95% (Primarily to Albumin) |
| Half-life | ~6 hours (AKBA) |
| Tmax | 2 - 4 hours |
| Metabolism | Hepatic (CYP3A4, CYP2C9) |
| Excretion | Biliary/Fecal (>90%), Renal (<5%) |
Indian Frankincense is classified therapeutically as a Phytopharmaceutical Anti-inflammatory. Within the FDA's Established Pharmacologic Class system, it is recognized as an Aromatic Amino Acid [EPC] and a Non-Standardized Plant Allergenic Extract [EPC]. It is often grouped with other 5-LOX inhibitors, though it is the only widely used natural agent in this specific class.
Common questions about Indian Frankincense
Indian Frankincense is primarily used to manage chronic inflammatory conditions, most notably osteoarthritis and rheumatoid arthritis. Clinical studies suggest it helps reduce joint pain, increase mobility, and decrease swelling by inhibiting the production of inflammatory leukotrienes. Additionally, it is used as a supportive treatment for inflammatory bowel diseases like ulcerative colitis and respiratory issues such as asthma. Some individuals also use it for collagenous colitis to reduce intestinal inflammation. Because it works differently than traditional NSAIDs, it is often preferred by those who cannot tolerate drugs like ibuprofen. Always consult a healthcare provider to see if it is appropriate for your specific health needs.
The most frequently reported side effects of Indian Frankincense are gastrointestinal in nature, including nausea, acid reflux, stomach pain, and diarrhea. Some users may also experience mild headaches or dizziness, especially when first starting the supplement. Because it is a plant-based resin, skin rashes or itching can occur in individuals with sensitivities to the Burseraceae plant family. These side effects are generally mild and can often be minimized by taking the supplement with a meal containing fats. If side effects persist or become severe, it is important to discontinue use and speak with a doctor. Serious allergic reactions are rare but require immediate medical attention.
There is no known direct interaction between Indian Frankincense and alcohol; however, caution is still advised. Both alcohol and Indian Frankincense are processed by the liver, so combining them in large amounts could theoretically increase the metabolic load on hepatic pathways. Furthermore, alcohol can irritate the stomach lining, potentially worsening the gastrointestinal side effects sometimes caused by the resin. For those using Indian Frankincense to treat inflammatory conditions, alcohol should be limited as it can promote systemic inflammation and counteract the supplement's benefits. It is best to discuss your alcohol consumption with your healthcare provider to ensure it does not interfere with your treatment goals.
Indian Frankincense is generally considered unsafe for use during pregnancy. Historically, it has been used as an emmenagogue, which means it can stimulate blood flow to the uterus and potentially induce menstruation or uterine contractions. This poses a significant risk of miscarriage or premature labor, especially when taken in the high doses found in standardized extracts. There is also insufficient data regarding its effects on fetal development and long-term safety for the unborn child. Consequently, medical professionals strongly advise against its use for pregnant women or those trying to conceive. Always prioritize safer, well-established treatments during pregnancy under the guidance of an obstetrician.
Unlike fast-acting pain relievers, Indian Frankincense requires a period of 'loading' in the body to exert its full anti-inflammatory effects. Most patients begin to notice a reduction in joint pain or improved digestive symptoms after 2 to 4 weeks of consistent daily use. Some high-potency standardized extracts may show initial results in as little as 7 days, but the maximum therapeutic benefit is typically reached after 8 to 12 weeks. It is important to maintain a regular dosing schedule and take the supplement with food to ensure proper absorption. If you do not see any improvement after two months of consistent use, you should consult your doctor to re-evaluate your treatment plan.
Stopping Indian Frankincense suddenly does not typically cause a physical withdrawal syndrome like some prescription medications. However, if you are using it to manage a chronic inflammatory condition such as asthma or ulcerative colitis, a sudden discontinuation could lead to a 'rebound' effect where your symptoms return or flare up. This happens because the 5-LOX enzyme inhibition is removed, allowing pro-inflammatory leukotrienes to increase again. To avoid this, it is often recommended to gradually reduce your dose over a week or two while monitoring your symptoms. Always discuss your plan to stop the supplement with your healthcare provider to ensure your condition remains stable.
If you miss a dose of Indian Frankincense, you should take it as soon as you remember, provided you can take it with a meal. If it is nearly time for your next scheduled dose, it is better to skip the missed dose entirely and continue with your regular routine. You should never take two doses at once to make up for a missed one, as this significantly increases the likelihood of experiencing stomach upset or nausea. Consistency is key for the effectiveness of Indian Frankincense, so using a pill organizer or setting a daily reminder may be helpful. If you frequently miss doses, talk to your doctor about whether a once-daily high-potency formulation might be a better option for you.
There is no clinical evidence to suggest that Indian Frankincense causes weight gain. In fact, some preliminary research in animal models suggests that boswellic acids might help regulate lipid metabolism and potentially support weight management by reducing systemic inflammation. However, these effects have not been definitively proven in human clinical trials. If you experience unexpected weight changes while taking this supplement, it is more likely related to changes in your activity level due to reduced joint pain or other underlying health factors. Always report significant or rapid weight changes to your healthcare provider for a thorough evaluation.
Indian Frankincense can interact with several types of medications, so it must be used with caution. It may increase the effects of blood-thinning drugs like Warfarin or Aspirin, raising the risk of bleeding. It also inhibits certain liver enzymes (CYP3A4 and CYP2C9), which can cause other drugs—such as statins, blood pressure medications, or certain antidepressants—to build up to higher levels in your blood. Additionally, it should not be taken with immunosuppressants, as it may interfere with their ability to control the immune system. Because of these potential interactions, you must provide your doctor or pharmacist with a complete list of all medications and supplements you are currently taking.
Indian Frankincense is a natural botanical extract, so it is not 'generic' in the same way that synthetic prescription drugs like lisinopril or metformin are. Instead, it is available from many different manufacturers as a dietary supplement. However, there is a significant difference between basic 'Boswellia' powder and 'standardized' extracts. Standardized versions are processed to contain a specific, guaranteed percentage of active boswellic acids (like AKBA), ensuring more consistent results. While non-standardized versions may be cheaper, they are often less effective and vary in quality. When choosing a product, look for those that have been third-party tested for purity and potency to ensure you are getting a high-quality extract.